Back to SearchPrice-to-Earnings: the share price divided by annual earnings per share. It tells you how many dollars you pay for one dollar of yearly profit — below 25 is generally considered reasonably priced.The P/E ratio divided by the expected earnings growth rate. It puts the valuation in relation to growth — a PEG below 2 suggests you are not overpaying for the company's future growth.The share price relative to the company's book value (assets minus liabilities) per share. Below 3 means the market price is still anchored to the company's actual net assets.Enterprise value (market cap plus net debt) divided by EBITDA. A debt-aware valuation multiple that makes companies with different financing comparable — below 15 is generally considered fair. How fast sales are growing, measured as the compound annual growth rate over the last 3 years. Consistent growth above 10% signals strong demand for the company's products or services.Return on Equity: net income divided by shareholders' equity. It shows how efficiently the company turns investors' capital into profit — above 5% indicates solid profitability.Operating profit as a percentage of revenue. It shows how much of every sales dollar is left after running the core business — above 10% points to an efficient operation with pricing power.Net income divided by total assets. It shows how well the company uses everything it owns — factories, cash, inventory — to generate profit. Above 5% indicates productive use of assets. Liquid assets (cash and receivables) divided by short-term liabilities. It shows whether the company can pay its upcoming bills without selling inventory — above 1.5 means a comfortable cushion.Total debt divided by shareholders' equity. It measures how much the company relies on borrowed money — below 1.0 means the business is financed more by its owners than by lenders.Free cash flow relative to the share price. Positive means the business generates more cash than it spends — real money available for dividends, buybacks or reinvestment.Annual dividends per share divided by the share price — the cash return you receive just for holding the stock. Shown for context only; many excellent companies pay no dividend.
Bristol-Myers Squibb Co
BMY
Pharmaceuticals • Pharmaceuticals
$64.84
+0.12 (+0.19%)
Market Cap: $132.2B
Price Chart
Valuation
Is the stock reasonably priced for what you get?
P/E Ratio
14.3
Target: < 25 Criteria met
PEG Ratio
-8.7
Target: < 2.0 Not met
Price/Book Ratio
5.9
Target: < 3.0 Not met
EV/EBITDA
N/A
Target: < 15Data not available
Growth & Profitability
How fast is the business growing and how efficiently does it earn money?
Revenue Growth
1.4%
Target: > 10% Not met
ROE
38.2%
Target: > 5% Criteria met
Operating Margin
21.5%
Target: > 10% Criteria met
Return on Assets
7.8%
Target: > 5% Criteria met
Financial Health
Can the company comfortably cover its obligations?
Quick Ratio
1.1
Target: > 1.5 Not met
Debt/Equity Ratio
2.4
Target: < 1.0 Not met
Free Cash Flow Yield
N/A
Target: > 0%Data not available
Dividend Yield
3.89%
Informational